Recent Publications

  1. Dieli-Conwright, C.M., Courneya, K.S., Demark-Wahnefried, W., Sami, N., Lee, K., Sweeney, F.C., Stewart, C., Buchanan, T.A., Spicer, D., Tripathy, D., Bernstein, L., & Mortimer, J.E. (2018). Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial. Breast Cancer Research, 20, Article number: 124.
  2. Liu, J., Geng, A., Wu, X., Lin, R.J., & Lu, Q. (2018). Alternative RNA Splicing Associated With Mammalian Neuronal Differentiation. Cerebral Cortex, 28(8), 2810-6.
  3. Gu, L., Lingeman, R., Yakushijin, F., Sun, E., Cui, Q., Chao, J., Hu, W., Li, H., Hickey, R.J., Stark, J.M., Yuan, Y.C., Chen, Y., Vonderfecht, S.L., Synold, T.W., Shi, Y., Reckamp, K.L., Horne, D., & Malkas, L.H. (2018). The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA. Clinical Cancer Research, 24(23), 6053-65.
  4. Wang, Y., Hoinka, J., Liang, Y., Adamus, T., Swiderski, P., & Przytycka, T.M. (2018). AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems. Nucleic Acids Research, 46(16), 8133-42.
  5. Seewaldt, V.L. (2018). Aspirin and Chemoprevention-Have We Arrived? JAMA Oncol, 4(12), 1668-9.
  6. Soto-Perez-de-Celis, E., Sun, C.L., Tew, W.P., Mohile, S.G., Gajra, A., Klepin, H.D., Owusu, C., Gross, C.P., Muss, H.B., Lichtman, S.M., Chapman, A.E., Cohen, H.J., Dale, W., Kim, H., Fernandes, S., Katheria, V., & Hurria, A. (2018). Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancer. Cancer, 124(15), 3249-56.
  7. Lin, H.H., Chung, Y., Cheng, C.T., Ouyang, C., Fu, Y., Kuo, C.Y., Chi, K.K., Sadeghi, M., Chu, P., Kung, H.J., Li, C.F., Limesand, K.H., & Ann, D.K. (2018). Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis. Autophagy, 14(9), 1481-98.
  8. Budde, L.E., Wu, D., Martin, D.B., Philip, M., Shustov, A.R., Smith, S.D., Gooley, T.A., Chen, T.L., Libby, E.N., Chen, E.Y., Kojouri, K., Langerak, A., Roden, J.E., Press, O.W., & Gopal, A.K. (2018). Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial. British Journal of Haematology, 183(4), 601-7. 
  9. Agarwal, N., Nussenzveig, R., & Pal, S.K. (2018). Biomarkers in renal-cell carcinoma: building on clinical paradigms. Lancet Oncology, 19(12), 1560-1.
  10. Mhaskar, R., & Djulbegovic, B. (2018). Bisphosphonates for Patients Diagnosed With Multiple Myeloma. JAMA, 320(14), 1483-4.
  11. Ring, A., Nguyen, C., Smbatyan, G., Tripathy, D., Yu, M., Press, M., Kahn, M., & Lang, J.E. (2018). CBP/beta-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer. Cancers, 10(12), Article number: 525.
  12. Chen, L., Youssef, Y., Robinson, C., Ernst, G.F., Carson, M.Y., Young, K.A., Scoville, S.D., Zhang, X., Harris, R., Sekhri, P., Mansour, A.G., Chan, W.K., Nalin, A.P., Mao, H.C., Hughes, T., Mace, E.M., Pan, Y., Rustagi, N., Chatterjee, S.S., Gunaratne, P.H., Behbehani, G.K., Mundy-Bosse, B.L., Caligiuri, M.A., & Freud, A.G. (2018). CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway. Immunity, 49(3), 464-76.e4.
  13. Scoville, S.D., Freud, A.G., & Caligiuri, M.A. (2018). Cellular pathways in the development of human and murine innate lymphoid cells. Current Opinion in Immunology, 56, 100-6.
  14. Li, R., Hou, W.H., Chao, J., Woo, Y., Glaser, S., Amini, A., Nelson, R.A., & Chen, Y.J. (2018). Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer. Journal of the National Comprehensive Cancer Network, 16(8), 950-8.
  15. Ogba, N., Arwood, N.M., Bartlett, N.L., Bloom, M., Brown, P., Brown, C., Budde, E.L., Carlson, R., Farnia, S., Fry, T.J., Garber, M., Gardner, R.A., Gurschick, L., Kropf, P., Reitan, J.J., Sauter, C., Shah, B., Shpall, E.J., & Rosen, S.T. (2018). Chimeric Antigen Receptor T-Cell Therapy. Journal of the National Comprehensive Cancer Network, 16(9), 1092-106.
  16. Tawbi, H.A., Forsyth, P.A., Algazi, A., Hamid, O., Hodi, F.S., Moschos, S.J., Khushalani, N.I., Lewis, K., Lao, C.D., Postow, M.A., Atkins, M.B., Ernstoff, M.S., Reardon, D.A., Puzanov, I., Kudchadkar, R.R., Thomas, R.P., Tarhini, A., Pavlick, A.C., Jiang, J., Avila, A., Demelo, S., & Margolin, K. (2018). Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain. New England Journal of Medicine, 379(8), 722-30.
  17. Fong, Y. (2018). Combining Antiviral Therapy With Tumor Resection as Optimal Treatment for Hepatocellular Carcinoma. JAMA Surg, 153(10), e182728.
  18. Massarelli, E., William, W., Johnson, F., Kies, M., Ferrarotto, R., Guo, M., Feng, L., Lee, J.J., Tran, H., Kim, Y.U., Haymaker, C., Bernatchez, C., Curran, M., Zecchini Barrese, T., Rodriguez Canales, J., Wistuba, I., Li, L., Wang, J., van der Burg, S.H., Melief, C.J., & Glisson, B. (2018). Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial. JAMA Oncol, 5(1), 67-73.
  19. Amini, A., Eguchi, M., Jones, B.L., Stokes, W.A., Gupta, A., McDermott, J.D., Massarelli, E., Bradley, C.J., & Karam, S.D. (2018). Comparing outcomes of concurrent chemotherapy regimens in patients 65 years old or older with locally advanced oropharyngeal carcinoma. Cancer, 124(22), 4322-31.
  20. Priceman, S.J., Gerdts, E.A., Tilakawardane, D., Kennewick, K.T., Murad, J.P., Park, A.K., Jeang, B., Yamaguchi, Y., Yang, X., Urak, R., Weng, L.H., Chang, W.C., Wright, S., Pal, S., Reiter, R.E., Wu, A.M., Brown, C.E., & Forman, S.J. (2018). Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA plus metastatic prostate cancer. Oncoimmunology, 7(2), Article number: e1380764.
  21. Das, S., Reddy, M.A., Senapati, P., Stapleton, K., Lanting, L., Wang, M., Amaram, V., Ganguly, R., Zhang, L.X., Devaraj, S., Schones, D.E., & Natarajan, R. (2018). Diabetes Mellitus-Induced Long Noncoding RNA Dnm3os Regulates Macrophage Functions and Inflammation via Nuclear Mechanisms. Arteriosclerosis Thrombosis and Vascular Biology, 38(8), 1806-20.
  22. Tsai, W.K., Zettlitz, K.A., Tavare, R., Kobayashi, N., Reiter, R.E., & Wu, A.M. (2018). Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody. Theranostics, 8(21), 5903-14.
  23. Murad, J.P., Kozlowska, A.K., Lee, H.J., Ramamurthy, M., Chang, W.C., Yazaki, P., Colcher, D., Shively, J., Cristea, M., Forman, S.J., & Priceman, S.J. (2018). Effective Targeting of TAG72(+) Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells. Frontiers in Immunology, 9, Article number: 2268.
  24. Ogura, M., Sancho, J.M., Cho, S.G., Nakazawa, H., Suzumiya, J., Tumyan, G., Kim, J.S., Lennard, A., Mariz, J., Ilyin, N., Jurczak, W., Lopez Martinez, A., Samoilova, O., Zhavrid, E., Yanez Ruiz, E., Trneny, M., Popplewell, L., Coiffier, B., Buske, C., Kim, W.S., Lee, S.J., Lee, S.Y., Bae, Y.J., & Kwak, L.W. (2018). Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial. Lancet Haematol, 5(11), e543-e53.
  25. Ghosh, S., Bierig, T., Lee, S., Jana, S., Löhle, A., Schnapp, G., Tautermann, C.S., & Vaidehi, N. (2018). Engineering Salt Bridge Networks between Transmembrane Helices Confers Thermostability in G-Protein-Coupled Receptors. Journal of Chemical Theory and Computation, 14(12), 6574–85.
  26. Levit, L.A., Singh, H., Klepin, H.D., & Hurria, A. (2018). Expanding the Evidence Base in Geriatric Oncology: Action Items From an FDA-ASCO Workshop. Journal of the National Cancer Institute, 110(11), 1163-70.
  27. Branciamore, S., Valo, Z., Li, M., Wang, J., Riggs, A.D., & Singer-Sam, J. (2018). Frequent monoallelic or skewed expression for developmental genes in CNS-derived cells and evidence for balancing selection. Proceedings of the National Academy of Sciences of the United States of America, 115(44), E10379-E86.
  28. Schork, A.J., Schork, M.A., & Schork, N.J. (2018). Genetic risks and clinical rewards. Nature Genetics, 50(9), 1210-1.
  29. Li, L., Tian, E., Chen, X., Chao, J., Klein, J., Qu, Q., Sun, G., Sun, G., Huang, Y., Warden, C.D., Ye, P., Feng, L., Li, X., Cui, Q., Sultan, A., Douvaras, P., Fossati, V., Sanjana, N.E., Riggs, A.D., & Shi, Y. (2018). GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. Cell Stem Cell, 23(2), 239-51.e6.
  30. Scoville, S.D., Nalin, A.P., Chen, L., Chen, L., Zhang, M.H., McConnell, K., Casas, S.B., Ernst, G., Al-Rahman Traboulsi, A., Hashi, N., Williams, M., Zhang, X., Hughes, T., Mishra, A., Benson, D.M., Saultz, J.N., Yu, J., Freud, A.G., Caligiuri, M.A., & Mundy-Bosse, B.L. (2018). Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function. Blood, 132(17), 1792-804.
  31. Egelston, C.A., Avalos, C., Tu, T.Y., Simons, D.L., Jimenez, G., Jung, J.Y., Melstrom, L., Margolin, K., Yim, J.H., Kruper, L., Mortimer, J., & Lee, P.P. (2018). Human breast tumor-infiltrating CD8(+) T cells retain polyfunctionality despite PD-1 expression. Nature Communications, 9, Article number: 4297.
  32. Slavin, T.P., Banks, K.C., Chudova, D., Oxnard, G.R., Odegaard, J.I., Nagy, R.J., Tsang, K.W.K., Neuhausen, S.L., Gray, S.W., Cristofanilli, M., Rodriguez, A.A., Bardia, A., Leyland-Jones, B., Janicek, M.F., Lilly, M., Sonpavde, G., Lee, C.E., Lanman, R.B., Meric-Bernstam, F., Kurzrock, R., & Weitzel, J.N. (2018). Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing. Journal of Clinical Oncology, 36(35), 3459-65.
  33. Thomaidou, S., Zaldumbide, A., & Roep, B.O. (2018). Islet stress, degradation and autoimmunity. Diabetes, Obesity & Metabolism, 20 Suppl 2, 88-94.
  34. Leung, A., & Natarajan, R. (2018). Long Noncoding RNAs in Diabetes and Diabetic Complications. Antioxidants and Redox Signaling, 29(11), 1064-73.
  35. Leung, A., Trac, C., Kato, H., Costello, K.R., Chen, Z., Natarajan, R., & Schones, D.E. (2018). LTRs activated by Epstein-Barr virus-induced transformation of B cells alter the transcriptome. Genome Research, 28(12), 1791-8.
  36. Poultsidi, A., Dimopoulos, Y., He, T.F., Chavakis, T., Saloustros, E., Lee, P.P., & Petrovas, C. (2018). Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells? Frontiers in Immunology, 9, Article number: 2233.
  37. Singhal, J., Singhal, P., Horne, D., Salgia, R., Awasthi, S., & Singhal, S.S. (2018). Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2 '-Hydroxyflavanone. Cancer Letters, 438, 144-53.
  38. Liu, X., Cao, M., Palomares, M., Wu, X., Li, A., Yan, W., Fong, M.Y., Chan, W.C., & Wang, S.E. (2018). Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type i collagen deposition by osteoblasts. Breast Cancer Research, 20, Article number: 127.
  39. Pichiorri, F. (2018). Mice no longer immune to immunomodulatory drugs. Blood, 132(14), 1470-1.
  40. Maughan, B.L., Pal, S.K., Gill, D., Boucher, K., Martin, C., Salgia, M., Nussenzveig, R., Liu, T., Hawks, J.L., Batten, J., Nachaegari, G., Stephenson, R., Lowrance, W., Jones, J., Dechet, C., & Agarwal, N. (2018). Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial. Oncologist, 23(12), 1413-e151.
  41. Lv, Z.Y., Yuan, L.M., Atkison, J.H., Williams, K.M., Vega, R., Sessions, E.H., Divlianska, D.B., Davies, C., Chen, Y., & Olsen, S.K. (2018). Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme. Nature Communications, 9, Article number: 5145.
  42. Das, S., Zhang, E.L., Senapati, P., Amaram, V., Reddy, M.A., Stapleton, K., Leung, A., Lanting, L., Wang, M., Chen, Z., Kato, M., Oh, H.J., Guo, Q.Y., Zhang, X., Zhang, B.Y., Zhang, H.T., Zhao, Q.H., Wang, W., Wu, Y.J., & Natarajan, R. (2018). A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells. Circulation Research, 123(12), 1298-312.
  43. Salunkhe, V.A., Veluthakal, R., Kahn, S.E., & Thurmond, D.C. (2018). Novel approaches to restore beta cell function in prediabetes and type 2 diabetes. Diabetologia, 61(9), 1895-901.
  44. Xu, B., Ma, R., Russell, L., Yoo, J.Y., Han, J., Cui, H., Yi, P., Zhang, J., Nakashima, H., Dai, H., Chiocca, E.A., Kaur, B., Caligiuri, M.A., & Yu, J. (2018). An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma. Nature Biotechnology, 37, 45-62.
  45. Sun, W.L., Malvar, J., Sposto, R., Verma, A., Wilkes, J.J., Dennis, R., Heym, K., Laetsch, T.W., Widener, M., Rheingold, S.R., Oesterheld, J., Hijiya, N., Sulis, M.L., Huynh, V., Place, A.E., Bittencourt, H., Hutchinson, R., Messinger, Y., Chang, B., Matioub, Y., Ziegler, D.S., Gardner, R., Cooper, T., Ceppi, F., Hermiston, M., Dalla-Pozza, L., Schultz, K.R., Gaynon, P., Wayne, A.S., & Whitlock, J.A. (2018). Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia, 32(11), 2316-25.
  46. Komatsu, H., Cook, C.A., Gonzalez, N., Medrano, L., Salgado, M., Sui, F., Li, J., Kandeel, F., Mullen, Y., & Tai, Y.C. (2018). Oxygen transporter for the hypoxic transplantation site. Biofabrication, 11(1), Article number: 015011.
  47. Chen, Q., Kassab, M.A., Dantzer, F., & Yu, X. (2018). PARP2 mediates branched poly ADP-ribosylation in response to DNA damage. Nature Communications, 9, 3233.
  48. Weist, M.R., Starr, R., Aguilar, B., Chea, J., Miles, J.K., Poku, E., Gerdts, E., Yang, X., Priceman, S.J., Forman, S.J., Colcher, D., Brown, C.E., & Shively, J.E. (2018). PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with (89)Zr-Oxine. Journal of Nuclear Medicine, 59(10), 1531-7.
  49. Fathi, A.T., Erba, H.P., Lancet, J.E., Stein, E.M., Ravandi, F., Faderl, S., Walter, R.B., Advani, A.S., DeAngelo, D.J., Kovacsovics, T.J., Jillella, A., Bixby, D., Levy, M.Y., O'Meara, M.M., Ho, P.A., Voellinger, J., & Stein, A.S. (2018). A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML. Blood, 132(11), 1125-33.
  50. Margolin, K., Morishima, C., Velcheti, V., Miller, J.S., Lee, S.M., Silk, A.W., Holtan, S.G., Lacroix, A.M., Fling, S.P., Kaiser, J.C., Egan, J.O., Jones, M., Rhode, P.R., Rock, A.D., Cheever, M.A., Wong, H.C., & Ernstoff, M.S. (2018). Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors. Clinical Cancer Research, 24(22), 5552-61.
  51. Golfetto, O., Wakefield, D.L., Cacao, E.E., Avery, K.N., Kenyon, V., Jorand, R., Tobin, S.J., Biswas, S., Gutierrez, J., Clinton, R., Ma, Y., Horne, D.A., Williams, J.C., & Jovanovic-Talisman, T. (2018). A Platform To Enhance Quantitative Single Molecule Localization Microscopy. Journal of the American Chemical Society, 140(40), 12785-97.
  52. Mohile, S.G., Dale, W., Somerfield, M.R., Schonberg, M.A., Boyd, C.M., Burhenn, P.S., Canin, B., Cohen, H.J., Holmes, H.M., Hopkins, J.O., Janelsins, M.C., Khorana, A.A., Klepin, H.D., Lichtman, S.M., Mustian, K.M., Tew, W.P., & Hurria, A. (2018). Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. Journal of Clinical Oncology, 36(22), 2326-47.
  53. Querfeld, C., Leung, S., Myskowski, P.L., Curran, S.A., Goldman, D.A., Heller, G., Wu, X., Kil, S.H., Sharma, S., Finn, K.J., Horwitz, S., Moskowitz, A., Mehrara, B., Rosen, S.T., Halpern, A.C., & Young, J.W. (2018). Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile. Cancer Immunol Res, 6(8), 900-9.
  54. Feng, M., Marjon, K.D., Zhu, F., Weissman-Tsukamoto, R., Levett, A., Sullivan, K., Kao, K.S., Markovic, M., Bump, P.A., Jackson, H.M., Choi, T.S., Chen, J., Banuelos, A.M., Liu, J., Gip, P., Cheng, L., Wang, D., & Weissman, I.L. (2018). Programmed cell removal by calreticulin in tissue homeostasis and cancer. Nature Communications, 9, Article number: 3194.
  55. Slavin, T.P., Van Tongeren, L.R., Behrendt, C.E., Solomon, I., Rybak, C., Nehoray, B., Kuzmich, L., Niell-Swiller, M., Blazer, K.R., Tao, S., Yang, K., Culver, J.O., Sand, S., Castillo, D., Herzog, J., Gray, S.W., & Weitzel, J.N. (2018). Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry. Journal of the National Cancer Institute, 110(10), 1059-66.
  56. Shinde, A., Jones, B.L., Chen, Y.J., & Amini, A. (2018). Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference? Journal of Clinical Oncology, 36(24), 2566-7.
  57. Cassady, K., Martin, P.J., & Zeng, D. (2018). Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80. Frontiers in Immunology, 9, Article number: 3061.
  58. Li, Y.J., Du, L., Aldana-Masangkay, G., Wang, X., Urak, R., Forman, S.J., Rosen, S.T., & Chen, Y. (2018). Regulation of miR-34b/c-targeted gene expression program by SUMOylation. Nucleic Acids Research, 46(14), 7108-23.
  59. Yoon, S., Wu, X., Armstrong, B., Habib, N., & Rossi, J.J. (2018). An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRalpha Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma. Mol Ther Nucleic Acids, 14, 131-41.
  60. Yuh, B., Chan, K., & Wilson, T. (2018). Robotic Cystectomy—Moving from Innovation to Measurable Impact. European Urology, 74(4), 472-3.
  61. Gao, H., Zhang, I.Y., Zhang, L., Song, Y., Liu, S., Ren, H., Liu, H., Zhou, H., Su, Y., Yang, Y., & Badie, B. (2018). S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth. Cancer Letters, 439, 91-100.
  62. Sun, J., He, X., Zhu, Y., Ding, Z., Dong, H., Feng, Y., Du, J., Wang, H., Wu, X., Zhang, L., Yu, X., Lin, A., McDonald, T., Zhao, D., Wu, H., Hua, W.K., Zhang, B., Feng, L., Tohyama, K., Bhatia, R., Oberdoerffer, P., Chung, Y.J., Aplan, P.D., Boultwood, J., Pellagatti, A., Khaled, S., Kortylewski, M., Pichiorri, F., Kuo, Y.H., Carlesso, N., Marcucci, G., Jin, H., & Li, L. (2018). SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function. Cell Stem Cell, 23(3), 355-69.e9.
  63. Wang, Y., Chu, J., Yi, P., Dong, W., Saultz, J., Wang, Y., Wang, H., Scoville, S., Zhang, J., Wu, L.C., Deng, Y., He, X., Mundy-Bosse, B., Freud, A.G., Wang, L.S., Caligiuri, M.A., & Yu, J. (2018). SMAD4 promotes TGF-beta-independent NK cell homeostasis and maturation and antitumor immunity. Journal of Clinical Investigation, 128(11), 5123-36.
  64. Weitzel, J.N., Chao, E.C., Nehoray, B., Van Tongeren, L.R., LaDuca, H., Blazer, K.R., Slavin, T., Pesaran, T., Rybak, C., Solomon, I., Niell-Swiller, M., Dolinsky, J.S., Castillo, D., Elliott, A., Gau, C.L., Speare, V., & Jasperson, K. (2018). Somatic TP53 variants frequently confound germ-line testing results. Genetics in Medicine, 20(8), 809-16.
  65. Shrivastava, S., Charlins, P., Ackley, A., Embree, H., Dropulic, B., Akkina, R., Weinberg, M.S., & Morris, K.V. (2018). Stable Transcriptional Repression and Parasitism of HIV-1. Molecular Therapy - Nucleic Acids, 12, 12-8.
  66. Moreira, D., Adamus, T., Zhao, X., Su, Y.L., Zhang, Z., White, S.V., Swiderski, P., Lu, X., DePinho, R.A., Pal, S.K., & Kortylewski, M. (2018). STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers. Clinical Cancer Research, 24(23), 5948-62.
  67. Xu, H., Shi, R., Han, W., Cheng, J., Xu, X., Cheng, K., Wang, L., Tian, B., Zheng, L., Shen, B., Hua, Y., & Zhao, Y. (2018). Structural basis of 5' flap recognition and protein-protein interactions of human flap endonuclease 1. Nucleic Acids Research, 46(21), 11315-25.
  68. Xu, X., Shi, R., Zheng, L., Guo, Z., Wang, L., Zhou, M., Zhao, Y., Tian, B., Truong, K., Chen, Y., Shen, B., Hua, Y., & Xu, H. (2018). SUMO-1 modification of FEN1 facilitates its interaction with Rad9-Rad1-Hus1 to counteract DNA replication stress. Journal of Molecular Cell Biology, 10(5), 460-74.
  69. He, Z.H., Zhang, J., Huang, Z.F., Du, Q., Li, N., Zhang, Q., Chen, Y., & Sun, Z.M. (2018). Sumoylation of ROR gamma t regulates T(H)17 differentiation and thymocyte development. Nature Communications, 9, Article number: 4870.
  70. Li, R., Shinde, A., Chen, Y.J., Amini, A., Lee, S., Dellinger, T., Han, E., Wakabayashi, M., Nelson, R., Beriwal, S., & Glaser, S. (2018). Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer. International Journal of Radiation Oncology Biology Physics, 102(2), 373-82.
  71. Oh, E., Ahn, M., Afelik, S., Becker, T.C., Roep, B.O., & Thurmond, D.C. (2018). Syntaxin 4 expression in pancreatic β-cells promotes islet function and protects functional β-cell mass. Diabetes, 67(12), 2626-39.
  72. Zhang, K., Wang, J., Yang, L., Yuan, Y.C., Tong, T.R., Wu, J., Yun, X., Bonner, M., Pangeni, R., Liu, Z., Yuchi, T., Kim, J.Y., & Raz, D.J. (2018). Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 06 Biological Sciences 0601 Biochemistry and Cell Biology. Molecular Cancer, 17, Article number: 153.
  73. Hassamal, S., Miotto, K., Dale, W., & Danovitch, I. (2018). Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures. American Journal of Medicine, 131(11), 1382 e1- e6.
  74. Nardi, I., Reno, T., Yun, X.W., Sztain, T., Wang, J.M., Dai, H.F., Zheng, L., Shen, B.H., Kim, J., & Raz, D. (2018). Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3. International Journal of Cancer, 143(10), 2470-8.